Mylan (MYL) Gets FDA Approval for Biosimilar of Neulasta
Mylan N.V MYL and partner Biocon announced that the FDA has approved Fulphila, a biosimilar of Amgen’s AMGN Neulasta. The news comes as a significant boost for Mylan, given the potential market for Fulphilia. […]